Insulin Assay Standardization
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Diabetes, primarily type 2 diabetes, has increased in prevalence throughout the world and current projections suggest a continued rise worldwide for at least the next quarter century. Insulin resistance, which frequently accompanies obesity, is known to be a key factor in the pathogenic development of type 2 diabetes (1–6). Type 2 diabetes occurs when insulin secretion is no longer sufficient to compensate for the resistance to the actions of insulin. Measurements of insulin sensitivity and secretion are currently done only for research purposes and are only comparable in individual studies. There are no clinical applications for these measures. In fact, there are no criteria by which an individual could be classified as being insulin sensitive or resistant or as having mild, moderate, or severe impairment of insulin secretion. In theory, one could envision that knowledge of an individual's response to insulin or the ability to secrete insulin might be useful for selecting patients for intensified prevention efforts, in the choice of initial therapy upon onset of overt hyperglycemia, or in evaluating the response to therapy beyond glycemia. For example, if a person newly diagnosed with diabetes could be determined to be very insulin resistant, the choice of initial therapy could be a drug that primarily improves insulin sensitivity. On the other hand, if the person was only moderately insulin resistant but had more of a defect in insulin secretion, a drug that improves insulin secretion might …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Insulin Standardization Workgroup called for harmonization of the insulin assay to encourage the development of measures of insulin sensitivity and secretion that will be practical for clinical care (374).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [374]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Martin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158
Warram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Weyer, C., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.89 · Cited by 357
Haffner, S. M., Miettinen, H., Gaskill, S. P., & Stern, M. P. (1995) · Diabetes · doi:10.2337/diab.44.12.1386 · Cited by 303
Report of the American Diabetes Association's Task Force on Standardization of the Insulin Assay
Robbins, D. C., Andersen, L., Bowsher, R., Chance, R., Dinesen, B., Frank, B., Gingerich, R., Goldstein, D., Widemeyer, H.-M., Haffner, S., et al. (1996) · Diabetes · doi:10.2337/diab.45.2.242 · Cited by 179
Comparison of 11 Human Insulin Assays: Implications for Clinical Investigation and Research
Manley, S. E., Stratton, I. M., Clark, P. M., & Luzio, S. D. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.077784 · Cited by 170
Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup
Marcovina, S., Bowsher, R. R., Miller, W. G., Staten, M., Myers, G., Caudill, S. P., Campbell, S. E., Steffes, M. W., & Workgroup, F. T. I. S. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.082214 · Cited by 136
Self-citationβ-Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes
Festa, A., Williams, K., Hanley, A. J. G., & Haffner, S. M. (2008) · Diabetes · doi:10.2337/db07-0954 · Cited by 128
Toward standardization of insulin immunoassays
Miller, W. G., Thienpont, L. M., Van Uytfanghe, K., Clark, P. M., Lindstedt, P., Nilsson, G., Steffes, M. W., & for the Insulin Standardization Work Group (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118380 · Cited by 111
Self-citationIn Vitro and In Vivo Potency of Insulin Analogues Designed for Clinical Use
Vølund, A., Brange, J., Drejer, K., Jensen, I., Markussen, J., Ribel, U., Sørensen, A. R., & Schlichtkrull, J. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb02122.x · Cited by 73
Cabaleiro, D. R., Uytfanghe, K. V., Stove, V. V., Fiers, T., & Thienpont, L. M. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.088393 · Cited by 54
Rodríguez Cabaleiro, D., Stöckl, D., Kaufman, J. M., Fiers, T., & Thienpont, L. M. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.062505 · Cited by 44
Preanalytical, Analytical, and Computational Factors Affect Homeostasis Model Assessment Estimates
Manley, S. E., Luzio, S. D., Stratton, I. M., Wallace, T. M., & Clark, P. M. S. (2008) · Diabetes Care · doi:10.2337/dc08-0097 · Cited by 38
Heinemann, L. (2010) · Diabetes Care · doi:10.2337/dc10-0034 · Cited by 36
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Diabetes Care · doi:10.2337/dc11-9998 · Cited by 718
Lin, C.-W., Zhang, H., Li, M., Xiong, X., Chen, X., Chen, X., Dong, X. C., & Yin, X.-M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.011 · Cited by 408
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Markopoulou, P., Papanikolaou, E., Analytis, A., Zoumakis, E., & Siahanidou, T. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.02.041 · Cited by 300
Metadata
- Authors
- Staten, M. A., Stern, M. P., Miller, W. G., Steffes, M. W., Campbell, S. E., & Workgroup, F. T. I. S.
- Affiliations
- National Institutes of Health (US)
- Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas;
- Virginia Commonwealth University (US)
- University of Minnesota (US)
- American Diabetes Association (US)
- Corresponding author
- Staten, Myrlene A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-01-01
- Volume
- 33
- Issue
- 1
- Pages
- 205-206
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2797975
- OpenAlex
- W1981582333
- Cited by
- 102
- References
- 15
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 6 · 2020: 6 · 2019: 10 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 4 · 2014: 5 · 2013: 8 · 2012: 2
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, insulin sensitivity, obesity, hyperglycemia
- MeSH terms
- Insulin Secretion, Biological Assay, Humans, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.